durapatite has been researched along with transforming growth factor beta in 163 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (13.50) | 18.2507 |
| 2000's | 71 (43.56) | 29.6817 |
| 2010's | 55 (33.74) | 24.3611 |
| 2020's | 15 (9.20) | 2.80 |
| Authors | Studies |
|---|---|
| Galante, JO; Gombotz, WR; Purchio, AF; Sumner, DR; Turner, TM; Urban, RM | 1 |
| Bali, JP; Cousse, H; Cuq, P; Marcelli, C | 1 |
| Cook, SD; Rueger, DC; Salkeld, SL | 1 |
| Hou, W; SiTu, P | 1 |
| Aspenberg, P; Boström, M; Jeppsson, C; Wang, JS | 1 |
| Bessho, K; Fujimura, K; Iizuka, T; Konishi, Y; Kusumoto, K; Ogawa, Y | 1 |
| Itoh, T; Kim, KJ; Kotake, S | 1 |
| Chang, WH; Li, J; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Hang, YS; Liao, CJ; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Bostrom, MP; Cole, BJ; Lane, JM; Pritchard, TL; Sumner, DR; Tomin, E; Weiland, AJ | 1 |
| Dev, S; Dutton, JJ; Holck, DE; Imami, N; Khawly, J; Mittra, R; Proia, A | 1 |
| Aasen, AO; Falch, JA; Høgåsen, AK; Nordsletten, L | 1 |
| Koempel, JA; O'Grady, K; Patt, BS; Toriumi, DM; Wozney, J | 1 |
| Brown, KR; Chang, CH; Howard, BK; Leach, JL; Rosenthal, DI | 1 |
| Aspenberg, P; Boström, M; Jeppsson, C | 1 |
| Sasada, H; Takahashi, T; Tominaga, T; Watabe, N; Yokobori, AT; Yoshimoto, T | 1 |
| Chang, WH; Hung, TY; Lin, FH; Liu, HC; Sun, JS; Tsuang, YH | 1 |
| Higashinakagawa, M | 1 |
| Hosokawa, R; Kimoto, T; Kubo, T; Sato, Y; Wadamoto, M | 1 |
| Bessho, K; Fujimura, K; Iizuka, T; Konishi, Y; Kusumoto, K; Ogawa, Y; Yoshida, K | 1 |
| Chen, F; Han, L; Ma, Q; Mao, T; Wang, C; Wang, H; Zhang, S; Zhao, M | 1 |
| Coin, R; Haïkel, Y; Ruch, JV | 1 |
| Barboza, EP; Duarte, ME; Geolás, L; Riedel, GE; Sorensen, RG; Wikesjö, UM | 1 |
| Bünger, C; Goodman, SB; Lind, M; Overgaard, S; Song, Y; Søballe, K | 1 |
| Crooks, J; Matsaba, T; Ripamonti, U; Tasker, J | 1 |
| Atsumi, K; Itoh, H; Jin, QM; Kohgo, T; Kuboki, Y; Takita, H | 2 |
| Delling , G; Magin, MN | 1 |
| Crooks, J; Ripamonti, U; Rueger, DC | 1 |
| Dohi, Y; Horiuchi, K; Ichijima, K; Ikeuchi, M; Noshi, T; Ohgushi, H; Sugimura, M; Yonemasu, K; Yoshikawa, T | 1 |
| Jin, Q; Kuboki, Y; Takita, H | 1 |
| Crooks, J; Matsaba, T; Ramoshebi, LN; Ripamonti, U; Tasker, J; Teare, J | 1 |
| Hashizume, H; Kawakami, M; Minamide, A; Sakata, R; Tamaki, T | 1 |
| Attawia, MA; Borden, MD; Gorum, WJ; Laurencin, CT; Lieberman, JR; Lu, HH; Lu, LQ | 1 |
| Dai, J; Keller, ET; Lin, DL; Morris, MD; Patel, AH; Rohn, E; Tarnowski, CP; Zhang, J | 1 |
| Alam, MI; Asahina, I; Enomoto, S; Ohmamiuda, K; Takahashi, K; Yokota, S | 1 |
| Enomoto, S; Imai, Y; Masaka, K; Miki, T | 1 |
| Boden, SD; Hutton, WC; Kim, HS; Louis-Ugbo, J; Mayr, M; Minamide, A; Murakami, H; Suh, DY | 1 |
| Konishi, S; Nagayama, R; Nakamura, H; Seki, M; Yamano, Y | 1 |
| Itoh, S; Kikuchi, M; Koyama, Y; Shinomiya, K; Takakuda, K; Tanaka, J | 1 |
| Behrens, P; Bruns, J; Dorn, B; Gille, J; Kekow, J | 1 |
| Reyes-Botella, C; Ruiz, C; Vallecillo-Capilla, MF | 1 |
| Balling, H; Blattert, TR; Dalal, PS; Delling, G; Toth, CA; Weckbach, A | 1 |
| Shimakura, Y; Uchinuma, E; Yamzaki, Y | 1 |
| Belibasakis, G; Papadimitriou, S; Tziafas, D; Veis, A | 1 |
| Kinoshita, A; Sorensen, RG; Wikesjö, UM; Wozney, JM | 1 |
| Bakker, FC; Blokhuis, TJ; den Boer, FC; Haarman, HJ; Patka, P; Wippermann, BW | 1 |
| Chueh, SC; Hsu, FY; Huang, YC; Lin, FH; Sun, JS; Wang, YJ | 1 |
| D'Haese, PC; De Broe, ME; Verberckmoes, SC | 1 |
| Clavenna, A; Mukherjee, DP; Roberts, RA; Rogers, S; Smith, D; Tunkle, AS | 1 |
| Dohi, Y; Ikeuchi, M; Kirita, T; Kudo, A; Ohgushi, H; Okamoto, M; Shimaoka, H; Yonemasu, K | 1 |
| Cui, FZ; Guan, K; Liao, SS; Shi, SS; Sun, TS; Zhang, W; Zheng, YJ; Zhu, B | 1 |
| Brooks, RA; Clarke, SA; Lee, PT; Rushton, N | 1 |
| Akasaka, Y; Hamada, H; Ito, Y; Jimbow, K; Jin, HY; Nakasu, M; Ogawa, T; Ono, I; Yamashita, T | 1 |
| Bagnall, K; Gittens, SA; Löbenberg, R; Matyas, JR; Uludag, H | 1 |
| Itoh, S; Kikuchi, M; Koyama, Y; Matumoto, HN; Shinomiya, K; Takakuda, K; Tanaka, J | 1 |
| Cui, F; Hu, Y; Xiong, Z; Yan, Y; Zhang, C; Zhang, S | 1 |
| Attallah, E; Barnes, B; Boden, SD; Hutton, WC; Kraiwattanapong, C; Louis-Ugbo, J | 1 |
| Hirao, M; Kaito, T; Myoui, A; Ochi, T; Takaoka, K; Tamai, N; Tanaka, J; Yoshikawa, H | 1 |
| Blumenthal, NM; Miranda, DA; Sorensen, RG; Wikesjö, UM; Wozney, JM | 1 |
| Campbell, MJ; Carreon, LY; Dimar, JR; Glassman, SD; Johnson, JR; Puno, RM | 1 |
| di Silvio, L; Heliotis, M; Lavery, KM; Ripamonti, U; Tsiridis, E | 1 |
| Dellinger, JG; Eurell, JA; Jamison, RD; Stewart, M | 1 |
| Jin, HJ; Kaplan, DL; Kim, HJ; Li, C; Vepari, C | 1 |
| Aizawa, M; Chiba, K; Fujimi, TJ; Kanzawa, N; Matsumoto, H; Matsumoto, M; Morisue, H; Okada, I; Toyama, Y; Uchida, H | 1 |
| Aäritalo, V; Ekholm, E; Finnberg, C; Forsback, AP; Holmbom, J; Kuusilehto, A; Märtson, M; Penttinen, R; Salonen, J; Tommila, M; Yli-Urpo, A | 1 |
| Carstens, MH; Chao, M; Donovan, T; Sotelo, C | 1 |
| Akazawa, T; Arisue, M; Ito, K; Murata, M; Sasaki, T; Tabata, Y; Tazaki, J; Yamamoto, M | 1 |
| Fleming, J; Halpern, J; Hamming, D; Holt, GE; Lynch, CC; Martin, MD; Matrisian, LM; Schwartz, HS | 1 |
| Bünger, C; Jensen, TB; Lind, M; Overgaard, S; Rahbek, O; Søballe, K | 1 |
| Ewers, R; Stein, E; Turhani, D; Wanschitz, F; Weissenböck, M | 1 |
| Hollister, SJ; Hu, WW; Krebsbach, PH; Wang, Z | 1 |
| Nie, H; Wang, CH | 1 |
| Fu, YC; Nie, H; Soh, BW; Wang, CH | 1 |
| Dong, X; Shen, J; Wang, Q; Wu, T; Zhou, H | 1 |
| Fu, YC; Ho, ML; Nie, H; Wang, CH; Wang, CK | 1 |
| Ewers, R; Goriwoda, W; Hoering, B; Lagogiannis, G; Moser, D; Redl, H; Schopper, C; Spassova, E | 1 |
| Chung, HM; Eun Ahn, S; Gwak, SJ; Kim, BS; Kim, S; Kim, SS; Lee, SH; Song, JH | 1 |
| Han, DK; Jeon, O; Kim, BS; Song, SJ; Yang, HS | 1 |
| Cochran, DL; Ehrbar, M; Hämmerle, CH; Jung, RE; Thoma, DS; Weber, FE | 1 |
| Richter, PW; Ripamonti, U; Thomas, ME | 1 |
| Gwak, SJ; Kim, BS; Kim, SS | 1 |
| Aoki, K; Endo, M; Horiuchi, H; Ishigaki, N; Kato, H; Kim, YA; Murakami, N; Nakamura, I; Nakamura, K; Narita, N; Saito, N; Taruta, S; Usui, Y; Yamazaki, H | 1 |
| Blanchette, J; Bouvet, C; de Blois, D; Moreau, P; Moreau, S | 1 |
| Armbruster, FP; Graf, HL; Hilbig, H; Neuhaus, J; Stoeva, S | 1 |
| Cui, FZ; Hu, YY; Ruan, DK; Zhang, C; Zhang, SM | 1 |
| Bian, WG; Liang, FH; Peng, L; Xu, HZ | 1 |
| Freilich, M; Hortschansky, P; Kompali, R; Kuhn, L; M Patel, C; Schleier, P; Shafer, D; Wei, M | 1 |
| Jeon, O; Kim, BS; Kim, JH; Kwon, IK; Lee, SH; Rhie, JW | 1 |
| Lin, Y; Liu, L; Long, J; Tang, W; Tang, Y; Tian, W; Wang, H | 1 |
| Benevolenskaia, LI; Korotkova, TA; Toroptsova, NV | 1 |
| Bruun, JM; Jakobsen, SS; Larsen, A; Soballe, K; Stoltenberg, M | 1 |
| Cui, G; Liu, Y; Lu, Y; Tian, X; Xing, G; Yang, Q; Yu, S; Zhang, B; Zhao, Y | 1 |
| Fen, W; Han, Y; He, C; Liu, J; Lu, W; Ou, Y; Peng, L; Wang, D; Zeng, Y; Zhang, X; Zhou, K; Zhu, W | 1 |
| Ferreira, FM; Larson, R; Shibli, JA; Zétola, A | 1 |
| Cochran, DL; Jones, AA; Nevins, M; Schoolfield, J; Yamashita, M | 1 |
| Chen, C; Cui, F; Guo, X; Hong, J; Lan, S; Li, J; Pan, H; Zheng, Q; Zou, Z | 1 |
| E, LL; Liu, HC; Lv, Y; Shi, ZP; Su, F; Wang, DS; Wang, JZ; Wu, X | 1 |
| Ghodasra, JH; Glicksman, ZS; Hsu, EL; Hsu, WK; Polavarapu, M; Riaz, R; Roc, GC; Stock, SR | 1 |
| Feng, Q; Jin, H; She, Z; Tan, R; Wang, M; Yu, X | 1 |
| Ferretti, C; Klar, RM; Ripamonti, U; Roden, LC | 1 |
| Bae, JH; Choi, KH; Kim, HJ; Kim, SE; Kim, SJ; Song, HR; Yang, JH; Yun, YP | 1 |
| Gao, C; Gou, Z; Li, D; Ye, C; Zhu, Y | 1 |
| Baek, HR; Chang, BS; Koo, TY; Lee, CK; Lee, JH; Lee, KM; Yang, JJ; Yu, CH | 1 |
| Aoyagi, K; Baba, K; Ikemoto, S; Takeda, A; Uchinuma, E; Yamazaki, Y | 1 |
| Chesnoiu-Matei, I; Clark, E; Cretiu Vasiliu, CE; Nguyen, PD; Ricci, JL; Smay, JE; Szpalski, C; Warren, SM | 1 |
| Appleford, MR; Ong, JL; Pilia, M; Shiels, SM; Solomon, KD | 1 |
| Liu, B; Lun, DX | 1 |
| Gu, Y; Jia, L; Lineaweaver, WC; Qi, J; Wang, J; Zhang, F; Zhang, J; Zhen, X | 1 |
| Bumgardner, JD; Haggard, WO; Reves, BT | 1 |
| Cui, FZ; Cui, H; Guo, WG; Liu, HY; Müller, WE; Zhang, X; Zhang, Y | 1 |
| Cooper-White, JJ; Fitzpatrick, J; Little, DG; Mikulec, K; Peacock, L; Ruys, AJ; Schindeler, A; Yu, NY | 1 |
| Loperfido, C; Lozada, JL; Mesquida, J | 1 |
| Anchieta, RB; Coelho, PG; Guastaldi, FP; Janal, MN; Jimbo, R; Machado, LS; Marin, C; Montclare, J; Tovar, N; Yoo, D | 1 |
| Li, B; Lü, X; Wang, J; Zhang, Z; Zhao, L | 1 |
| Chen, L; Feng, Y; Gu, Y; Liu, HL; Niu, HY; Wang, CZ; Yang, HL; Zhang, C; Zhu, XS | 1 |
| Baek, HR; Chang, BS; Kong, CB; Lee, CK; Lee, JH | 1 |
| Ghayor, C; Jung, RE; Kruse, A; Thoma, DS; Weber, FE | 1 |
| Breitbart, EA; Doyle, E; Lin, S; Liporace, FA; Paglia, DN; Yoon, RS | 1 |
| Li, J; Tang, Z; Tu, Q; Xiong, L; Yan, L; Yao, A; Zeng, J | 1 |
| Ayers, DC; Kutikov, AB; Skelly, JD; Song, J | 1 |
| Barbieri, D; de Boer, J; Groen, N; Habibovic, P; Kanda, T; Sano, Y; Shimizu, F; Tahmasebi, N; van Blitterswijk, CA; Yuan, H | 1 |
| Chen, T; Gomez, AW; Hu, J; Li, J; Li, X; Li, Y; Zhang, Z; Zuo, Y | 1 |
| Qiu, G; Su, X; Wang, H; Wu, G; Wu, Z; Yang, G; Yin, B; Zhang, J; Zhang, X; Zhou, G; Zhou, K | 1 |
| Bhattacharjee, P; Bhattacharya, D; Kundu, SC; Maiti, TK; Naskar, D | 1 |
| Cao, G; Li, Q; Quan, R; Shao, R; Shi, Y; Xie, S; Yang, D; Zhang, L; Zhuang, W | 1 |
| Fan, Z; Lige, Z; Mengting, L; Shiran, G; Ting, H | 1 |
| Chen, C; Cui, W; Feng, Q; Guo, X; Ji, Y; Liu, W; Sun, T; Wang, M | 1 |
| Isaksson, H; Kumar, A; Lidgren, L; Raina, DB; Singh, C; Sinha, N; Tägil, M; Teotia, AK | 1 |
| Beck-Broichsitter, BE; Becker, ST; Seitz, H; Warnke, PH; Wiltfang, J | 1 |
| Egawa, S; Hirai, K; Matsumoto, R; Nakajima, T; Okawa, A; Sotome, S; Wei, X; Yasuda, H; Yoshii, T | 1 |
| Cancedda, R; El Backly, RM; Hilborn, J; Mastrogiacomo, M; Todeschi, MR; Varghese, OP | 1 |
| Choi, HM; Khureltogtokh, S; Kim, HJ; Lee, AR; Nam, JW; Park, YB | 1 |
| Deng, L; Kang, P; Li, D; Xie, X; Yang, Z | 1 |
| Du, WB; Jia, GY; Lv, LB; Quan, RF; Shao, RX; Wang, D; Wang, JF; Wang, T; Wei, XC; Xu, CY; Yang, DS | 1 |
| Basso, BS; Catarina, AV; Dias, HB; Donadio, MVF; Haute, GV; Lunardelli, A; Martha, BA; Melo, DADS; Nunes, FB; Oliveira, JR; Stülp, S; Tassinary, JAF | 1 |
| Isaksson, H; Kumar, A; Larsson, D; Lidgren, L; Mrkonjic, F; Raina, DB; Tägil, M | 1 |
| Auslander, A; Hammoudeh, J; Jedrzejewski, B; Leland, H; Liang, F; Magee, W; Maniskas, S; Swanson, J; Urata, M | 1 |
| Chen, Z; Lin, Z; Xia, H; Xia, Y; Ye, X; Yin, Q; Zhang, Y | 1 |
| Lin, K; Wu, J; Xia, Y; Xu, S; Yuan, Y; Zhang, H; Zhou, P | 1 |
| Isaksson, H; Kumar, A; Larsson, D; Lidgren, L; Qayoom, I; Raina, DB; Tägil, M; Zheng, MH | 1 |
| Dou, DD; Fan, YB; Fei, JJ; Guan, XL; Liu, HW; Liu, ML; Xiao, XF; Zhang, J; Zhou, G | 1 |
| Bydon, A; Choi, J; De la Garza Ramos, R; Elder, BD; Gokaslan, ZL; Ishida, W; Kosztowski, TA; Lo, SL; Ramhmdani, S; Sciubba, DM; Theodore, N; Witham, TF; Wolinsky, JP; Xia, Y; Xu, R | 1 |
| Edranov, SS; Kalinichenko, SG; Kostiv, RY; Matveeva, NY | 1 |
| Dalby, MJ; Hodgkinson, T; Kareem, MM; Sanchez, MS; Tanner, KE | 1 |
| Ding, LH; Li, JT; Liu, SW; Qiu, P; Xiao, ZB; Xiong, L; Xiong, SL; Zeng, JH; Zhang, T | 1 |
| Ding, L; Li, J; Liao, X; Liu, S; Long, Z; Qiu, P; Xiong, L; Xiong, S; Zeng, J; Zhou, J | 1 |
| Ding, L; Li, J; Liao, X; Qiu, P; Xiong, L; Xiong, S; Zeng, J; Zhou, J | 1 |
| Chen, Y; Huang, F; Huang, Y; Wang, H; Wu, G; Xie, Y; Zheng, L | 1 |
| Chee, YD; Nam, JW; Park, YB | 1 |
| Bahri, M; Dabirmanesh, B; Hasannia, S; Moshaverinia, A; Zadeh, HH | 1 |
| Amanbek, G; Anisimova, N; Bartov, M; Gromov, A; Grunina, T; Kaloshkin, S; Karyagina, A; Kiselevskiy, M; Knyazeva, M; Kolesnikov, E; Krivozubov, M; Lunin, V; Maksimkin, A; Manskikh, V; Nikitin, K; Orlova, P; Poponova, M; Scholz, R; Senatov, F; Strukova, N; Walther, F | 1 |
| Dang, LHN; Lee, KB | 1 |
| Farrell, E; Fernandes Patrício, TM; Garcia, SF; Montesi, M; Mumcuoglu, D; Panseri, S; Sandri, M; Sprio, S; Tampieri, A; Witte-Bouma, J | 1 |
| Bal, Z; Chijimatsu, R; Dede, EÇ; Gizer, M; Ishiguro, H; Kaito, T; Kodama, J; Korkusuz, F; Korkusuz, P; Kushioka, J; Nakagawa, S; Okada, R; Tateiwa, D; Ukon, Y; Yoshikawa, H | 1 |
| Çetin Altındal, D; Gümüşderelioğlu, M; Jarrar, H | 1 |
| E, LL; Li, CJ; Liu, HC; Ma, XC; Xiao, R; Zhang, R; Zhang, S | 1 |
| Benic, GI; Jung, UW; Lim, HC; Paeng, KW | 1 |
| Ellenbogen, DJ; Greene, AC; Hallman, MJ; Hsu, EL; Hsu, WK; Jakus, AE; Lyons, J; Minardi, S; Plantz, M; Procissi, D; Shah, RN; Shah, V; Yamaguchi, JT; Yun, C | 1 |
| Jiang, X; Ren, H; Shang, Q; Shen, G; Yu, X; Zhang, P; Zhang, Z; Zhao, W | 1 |
| Cho, JW; Choi, W; Kim, H; Lim, EJ; Oh, JK; Sakong, S; Son, WS | 1 |
| Byun, SH; Choi, HG; Hong, SJ; Lim, HK; On, SW; Ryu, JI; Yang, BE; Yi, SM | 1 |
| Choi, JY; Kang, CN; Park, HJ; Park, SM; Song, KS | 1 |
6 review(s) available for durapatite and transforming growth factor beta
| Article | Year |
|---|---|
[Advances in the experimental studies of hydroxylapatite-based composites].
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Durapatite; Growth Substances; Prostheses and Implants; Transforming Growth Factor beta | 1995 |
[The role of ossein-hydroxyapatite complex in osteoporosis prophylaxis (review)].
Topics: Biocompatible Materials; Bone Density; Durapatite; Humans; Osteoporosis; Somatomedins; Transforming Growth Factor beta | 2008 |
Biomimetic matrices self-initiating the induction of bone formation.
Topics: Animals; Biomimetic Materials; Bone Morphogenetic Proteins; Calcium Phosphates; Cell Differentiation; Durapatite; Humans; Osteogenesis; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2011 |
Current application of β-tricalcium phosphate composites in orthopaedics.
Topics: Biocompatible Materials; Bone Marrow; Bone Morphogenetic Protein 2; Calcium Phosphates; Durapatite; Factor XIIIa; Humans; Ions; Metals; Orthopedic Procedures; Orthopedics; Platelet-Rich Plasma; Polyesters; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2012 |
Alternatives to Autologous Bone Graft in Alveolar Cleft Reconstruction: The State of Alveolar Tissue Engineering.
Topics: Alveolar Process; Autografts; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 7; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Cleft Palate; Durapatite; Humans; Maxilla; Plastic Surgery Procedures; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta; Transplantation, Autologous | 2018 |
Bone repair scaffold coated with bone morphogenetic protein-2 for bone regeneration in murine calvarial defect model: Systematic review and quality evaluation.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Durapatite; Humans; Mice; Models, Animal; Plastic Surgery Procedures; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Reproducibility of Results; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2019 |
4 trial(s) available for durapatite and transforming growth factor beta
| Article | Year |
|---|---|
Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
Topics: Adult; Aged; Aged, 80 and over; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Calcium Phosphates; Collagen; Drug Carriers; Durapatite; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Smoking; Spinal Diseases; Spinal Fusion; Statistics, Nonparametric; Transforming Growth Factor beta | 2005 |
Randomised controlled clinical trial of augmentation of the alveolar ridge using recombinant human bone morphogenetic protein 2 with hydroxyapatite and bovine-derived xenografts: comparison of changes in volume.
Topics: Adult; Aged; Aged, 80 and over; Alveolar Bone Loss; Alveolar Process; Alveolar Ridge Augmentation; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Transplantation; Cattle; Durapatite; Female; Heterografts; Humans; Male; Middle Aged; Organ Size; Recombinant Proteins; Single-Blind Method; Transforming Growth Factor beta; Young Adult | 2017 |
Preclinical Safety of a 3D-Printed Hydroxyapatite-Demineralized Bone Matrix Scaffold for Spinal Fusion.
Topics: Animals; Bone Matrix; Bone Morphogenetic Protein 2; Bone Transplantation; Durapatite; Female; Lumbar Vertebrae; Printing, Three-Dimensional; Prospective Studies; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2022 |
Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-bli
Topics: Bone Morphogenetic Protein 2; Durapatite; Escherichia coli; Humans; Lumbar Vertebrae; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Spinal Diseases; Spinal Fusion; Transforming Growth Factor beta; Treatment Outcome | 2022 |
153 other study(ies) available for durapatite and transforming growth factor beta
| Article | Year |
|---|---|
Enhancement of bone ingrowth by transforming growth factor-beta.
Topics: Animals; Bone Nails; Calcium Phosphates; Dogs; Durapatite; Humerus; Male; Microscopy, Electron, Scanning; Osseointegration; Recombinant Proteins; Time Factors; Titanium; Transforming Growth Factor beta | 1995 |
[Effects of an hydrosoluble fraction from bovine bone (Ossopan) on murine osteoblasts in culture].
Topics: Animals; Animals, Newborn; Bone and Bones; Cattle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Durapatite; Ethanol; In Vitro Techniques; Osteoblasts; Rats; Recombinant Proteins; Solubility; Transforming Growth Factor beta | 1995 |
Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites.
Topics: Alveolar Process; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Regeneration; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis Design; Dogs; Durapatite; Evaluation Studies as Topic; Growth Substances; Humans; Male; Mandible; Osseointegration; Osteogenesis; Proteins; Recombinant Proteins; Time Factors; Tooth Extraction; Transforming Growth Factor beta; Wound Healing | 1995 |
Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats.
Topics: Animals; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Durapatite; Male; Porosity; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Regression Analysis; Tibia; Titanium; Transforming Growth Factor beta | 1996 |
Self-regenerating bone implant: ectopic osteoinduction following intramuscular implantation of a combination of rhBMP-2, atelopeptide type I collagen and porous hydroxyapatite.
Topics: Animals; Biocompatible Materials; Bone Marrow; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Collagen; Drug Carriers; Durapatite; Erythrocytes; Humans; Male; Mesoderm; Muscle, Skeletal; Osteoblasts; Osteogenesis; Porosity; Radiography; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 1996 |
Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials.
Topics: Adult; Alkaline Phosphatase; Alloys; Animals; Biocompatible Materials; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Culture Techniques; Cobalt; Colony-Forming Units Assay; Durapatite; Hematopoietic Stem Cells; Humans; Mice; Middle Aged; Osteoblasts; Rats; Recombinant Proteins; Stromal Cells; Titanium; Transforming Growth Factor beta | 1997 |
Effect of hydroxyapatite particle size on myoblasts and fibroblasts.
Topics: Animals; Cell Count; Cell Membrane; Cell Size; Coculture Techniques; Culture Media; Dinoprostone; Durapatite; Female; Fibroblasts; Male; Muscle, Skeletal; Particle Size; Rats; Rats, Wistar; Transforming Growth Factor beta | 1997 |
The effects of calcium phosphate particles on the growth of osteoblasts.
Topics: Alkaline Phosphatase; Animals; Animals, Newborn; Calcium Phosphates; Calcium Pyrophosphate; Cell Count; Cell Division; Cells, Cultured; Ceramics; Culture Media; Dinoprostone; Durapatite; Osteoblasts; Powders; Rats; Rats, Wistar; Transforming Growth Factor beta | 1997 |
Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat.
Topics: Analysis of Variance; Animals; Bone and Bones; Bone Marrow; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cartilage; Chi-Square Distribution; Durapatite; Humans; Microscopy, Electron, Scanning; Muscle, Skeletal; Ossification, Heterotopic; Osteogenesis; Porosity; Prostheses and Implants; Prosthesis Implantation; Radiography; Rats; Rats, Inbred Lew; Recombinant Proteins; Single-Blind Method; Surface Properties; Titanium; Transforming Growth Factor beta | 1997 |
Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-beta 2, and autogenous plasma.
Topics: Animals; Biocompatible Materials; Blood; Durapatite; Gentamicins; Neovascularization, Physiologic; Orbit; Osseointegration; Pilot Projects; Postoperative Complications; Prostheses and Implants; Rabbits; Recombinant Proteins; Sodium Chloride; Transforming Growth Factor beta | 1998 |
17 beta-Oestradiol and 1 alpha,25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1 beta (IL-1 beta) production by peripheral blood mononuclear cells isolated from postmenopausal women.
Topics: Bone Matrix; Calcitriol; Cells, Cultured; Collagen; Durapatite; Estradiol; Female; Hot Temperature; Humans; Interleukin-1; Leukocytes, Mononuclear; Middle Aged; Postmenopause; Protein Denaturation; Transforming Growth Factor beta | 1998 |
The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Durapatite; Humans; Osseointegration; Prostheses and Implants; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 1998 |
Osteoinduction using bone morphogenic protein in irradiated tissue.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Durapatite; Implants, Experimental; Male; Microscopy, Electron, Scanning; Osseointegration; Rabbits; Random Allocation; Recombinant Proteins; Transforming Growth Factor beta | 1998 |
Intraosseous BMP implants in rabbits. Inhibitory effect on bone formation.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bony Callus; Collagen; Drug Carriers; Drug Evaluation, Preclinical; Drug Implants; Durapatite; Osteogenesis; Rabbits; Rats; Transforming Growth Factor beta | 1999 |
Use of porous hydroxyapatite graft containing recombinant human bone morphogenetic protein-2 for cervical fusion in a caprine model.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cervical Vertebrae; Dose-Response Relationship, Drug; Durapatite; Female; Goats; Humans; Recombinant Proteins; Spinal Fusion; Tomography, X-Ray Computed; Transforming Growth Factor beta | 1999 |
The influence of hydroxyapatite particles on osteoclast cell activities.
Topics: Alkaline Phosphatase; Animals; Animals, Newborn; Apoptosis; Biocompatible Materials; Cell Count; Culture Media; Dinoprostone; Durapatite; Immunohistochemistry; L-Lactate Dehydrogenase; Osteoblasts; Osteoclasts; Particle Size; Powders; Rats; Rats, Wistar; Spleen; Transforming Growth Factor beta | 1999 |
[Biological effects of basic fibroblast growth factor (bFGF) and osteogenic protein-1 (OP-1/BMP-7) on bone marrow cells and development of cell-hybrid artificial bone].
Topics: Animals; Biocompatible Materials; Bone Marrow Cells; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Cells, Cultured; Durapatite; Fibroblast Growth Factor 2; In Vitro Techniques; Osteogenesis; Rats; Rats, Wistar; Transforming Growth Factor beta | 1999 |
Direct bone induction in the subperiosteal space of rat calvaria with demineralized bone allografts.
Topics: Animals; Bone Morphogenetic Proteins; Bone Transplantation; Chondrogenesis; Decalcification Technique; Durapatite; Freeze Drying; Male; Osteogenesis; Rats; Rats, Wistar; Skull; Transforming Growth Factor beta | 1999 |
Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects.
Topics: Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Collagen; Drug Carriers; Durapatite; Humans; Male; Mandible; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
An experimental study on rhBMP-2 composite bone substitute for repairing craniomaxillary bone defects.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Bone Transplantation; Chitin; Cnidaria; Collagen; Drug Carriers; Drug Combinations; Durapatite; Humans; Mandible; Rabbits; Rats; Recombinant Proteins; Skull; Transforming Growth Factor beta | 1998 |
Effects of apatite, transforming growth factor beta-1, bone morphogenetic protein-2 and interleukin-7 on ameloblast differentiation in vitro.
Topics: Ameloblasts; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cell Lineage; Cell Polarity; Culture Techniques; Durapatite; Enamel Organ; Growth Substances; Humans; Interleukin-7; Mice; Recombinant Proteins; Transforming Growth Factor beta | 1999 |
Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Topics: Absorbable Implants; Alveolar Process; Alveolar Ridge Augmentation; Alveolectomy; Animals; Bicuspid; Biocompatible Materials; Biopsy; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Collagen; Disease Models, Animal; Dogs; Drug Carriers; Durapatite; Humans; Mandible; Mouth Mucosa; Pilot Projects; Pressure; Recombinant Proteins; Surgical Flaps; Tooth Extraction; Transforming Growth Factor beta; Wound Healing | 2000 |
Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Coated Materials, Biocompatible; Dogs; Durapatite; Osseointegration; Prostheses and Implants; Titanium; Transforming Growth Factor beta; Wound Healing | 2000 |
Induction of endochondral bone formation by recombinant human transforming growth factor-beta2 in the baboon (Papio ursinus).
Topics: Animals; Biocompatible Materials; Bone Regeneration; Chondrocytes; Collagen; Durapatite; Implants, Experimental; Osteogenesis; Papio; Recombinant Proteins; Rectus Abdominis; Skull; Transforming Growth Factor beta | 2000 |
Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation.
Topics: Alkaline Phosphatase; Animals; Base Sequence; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; DNA Primers; Drug Implants; Durapatite; Humans; Male; Materials Testing; Microscopy, Electron, Scanning; Osteocalcin; Osteogenesis; Particle Size; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2000 |
Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cartilage; Cattle; Drug Carriers; Drug Implants; Durapatite; Humans; Male; Materials Testing; Microscopy, Electron, Scanning; Neovascularization, Physiologic; Osteocalcin; Osteogenesis; Particle Size; Porosity; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Transplantation; Durapatite; Female; Intervertebral Disc; Intervertebral Disc Displacement; Lumbar Vertebrae; Magnetic Resonance Imaging; Neuroprotective Agents; Radionuclide Imaging; Reproducibility of Results; Sheep; Spinal Fusion; Tomography, X-Ray Computed; Transforming Growth Factor beta; Transplantation, Autologous; Wound Healing | 2001 |
Induction of bone formation by recombinant human osteogenic protein-1 and sintered porous hydroxyapatite in adult primates.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Coated Materials, Biocompatible; Dose-Response Relationship, Drug; Durapatite; Humans; Male; Osseointegration; Papio; Recombinant Proteins; Transforming Growth Factor beta | 2001 |
Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone and Bones; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Ceramics; Durapatite; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Implants, Experimental; Male; Osteoblasts; Osteocalcin; Osteogenesis; Rats; Rats, Inbred F344; Recombinant Proteins; Stem Cells; Transforming Growth Factor beta | 2001 |
Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Chondrogenesis; Drug Carriers; Durapatite; Glass; Osteogenesis; Porosity; Prostheses and Implants; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2001 |
Bone induction by BMPs/OPs and related family members in primates.
Topics: Abdominal Muscles; Animals; Biocompatible Materials; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Collagen; Drug Carriers; Drug Delivery Systems; Durapatite; Implants, Experimental; Osteogenesis; Papio; Skull; Transforming Growth Factor beta | 2001 |
Evaluation of carriers of bone morphogenetic protein for spinal fusion.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Cattle; Collagen; Crystallization; Drug Carriers; Durapatite; Humans; Ilium; Materials Testing; Models, Animal; Palpation; Protein Structure, Secondary; Rabbits; Radiography; Recombinant Proteins; Spinal Fusion; Spine; Survival Rate; Transforming Growth Factor beta | 2001 |
Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Cell Adhesion; Cell Line; Durapatite; Genetic Therapy; Mice; Mice, SCID; Polyglactin 910; Retroviridae; Transforming Growth Factor beta | 2001 |
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
Topics: Anthraquinones; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Neoplasms; Calcinosis; Calcium; Cell Division; Core Binding Factor Alpha 1 Subunit; Durapatite; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Male; Neoplasm Proteins; Osteoblasts; Osteoprotegerin; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Staining and Labeling; Transcription Factors; Transforming Growth Factor beta; Tumor Cells, Cultured | 2001 |
Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2.
Topics: Alkaline Phosphatase; Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Connective Tissue; Connective Tissue Cells; Delayed-Action Preparations; Drug Carriers; Drug Implants; Durapatite; Humans; Male; Materials Testing; Microscopy, Electron, Scanning; Osteoblasts; Osteocytes; Osteogenesis; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta | 2001 |
Experience with freeze-dried PGLA/HA/rhBMP-2 as a bone graft substitute.
Topics: Absorbable Implants; Analysis of Variance; Animals; Biocompatible Materials; Bone Diseases; Bone Marrow; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Connective Tissue; Durapatite; Follow-Up Studies; Freeze Drying; Humans; Lactic Acid; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Radiography; Rats; Recombinant Proteins; Skull; Statistics as Topic; Transforming Growth Factor beta | 2000 |
Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium Phosphates; Ceramics; Collagen Type I; Compressive Strength; Drug Administration Routes; Drug Carriers; Drug Evaluation, Preclinical; Durapatite; Humans; Implants, Experimental; Lumbar Vertebrae; Lumbosacral Region; Macaca mulatta; Models, Animal; Osteogenesis; Rabbits; Recombinant Proteins; Spinal Fusion; Surgical Sponges; Tomography, X-Ray Computed; Transforming Growth Factor beta; Treatment Outcome | 2002 |
Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Transplantation; Combined Modality Therapy; Durapatite; Joint Instability; Lumbar Vertebrae; Rabbits; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2002 |
Development of an artificial vertebral body using a novel biomaterial, hydroxyapatite/collagen composite.
Topics: Animals; Biocompatible Materials; Bone Conduction; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cervical Vertebrae; Collagen; Dogs; Durapatite; Materials Testing; Polyesters; Radiography; Recombinant Proteins; Time Factors; Titanium; Transforming Growth Factor beta; X-Rays | 2002 |
Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1)).
Topics: Biocompatible Materials; Bone Substitutes; Drug Delivery Systems; Durapatite; Humans; Minerals; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Effect of different growth factors on human cultured osteoblast-like cells.
Topics: Adult; Alkaline Phosphatase; Antibody Specificity; Cell Adhesion; Cells, Cultured; Coated Materials, Biocompatible; Durapatite; Female; Fibroblast Growth Factors; Flow Cytometry; Humans; Hyaluronan Receptors; Interleukin-2; Male; Neprilysin; Osteoblasts; Osteocalcin; Receptors, Interleukin-2; Thymidine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tritium | 2002 |
Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine.
Topics: Animals; Bone Cements; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Drug Carriers; Drug Evaluation, Preclinical; Drug Implants; Durapatite; Endoscopy; Female; Ilium; Lumbar Vertebrae; Models, Animal; Osteogenesis; Prospective Studies; Radiography; Sheep; Spinal Fusion; Spine; Transforming Growth Factor beta; Transplantation, Autologous; Treatment Outcome | 2002 |
Experimental study on bone formation potential of cryopreserved human bone marrow mesenchymal cell/hydroxyapatite complex in the presence of recombinant human bone morphogenetic protein-2.
Topics: Adult; Animals; Biocompatible Materials; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Cells, Cultured; Child; Cryopreservation; Culture Media; Dermatologic Surgical Procedures; Durapatite; Female; Humans; Hybrid Cells; Male; Mesoderm; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Animal; Osteogenesis; Recombinant Proteins; Time Factors; Tissue Engineering; Transforming Growth Factor beta; Transplantation, Autologous | 2003 |
Dentin regeneration in vital pulp therapy: design principles.
Topics: Animals; Biocompatible Materials; Calcium Hydroxide; Cell Differentiation; Dental Pulp; Dental Pulp Capping; Dental Pulp Exposure; Dentin; Dentin, Secondary; Dentinogenesis; Dogs; Drug Carriers; Drug Delivery Systems; Durapatite; Extracellular Matrix; Membranes, Artificial; Micropore Filters; Odontoblasts; Regeneration; Surface Properties; Titanium; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2001 |
RhBMP-2/alphaBSM induces significant vertical alveolar ridge augmentation and dental implant osseointegration.
Topics: Alveolar Ridge Augmentation; Animals; Bone Cements; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Dental Implantation, Endosseous; Dental Implants; Dogs; Drug Carriers; Durapatite; Humans; Hydroxyapatites; Implants, Experimental; Male; Mandible; Osseointegration; Recombinant Proteins; Transforming Growth Factor beta | 2002 |
Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Marrow Transplantation; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Durapatite; Female; Fracture Healing; Fractures, Bone; Humans; Radiography; Recombinant Proteins; Sheep; Tibia; Torsion Abnormality; Transforming Growth Factor beta; Transplantation, Autologous | 2003 |
Collagen-hydroxyapatite/tricalcium phosphate microspheres as a delivery system for recombinant human transforming growth factor-beta 1.
Topics: Animals; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; Drug Delivery Systems; Durapatite; Femur; Male; Microspheres; Rabbits; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2003 |
Dose-dependent effects of strontium on osteoblast function and mineralization.
Topics: Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcification, Physiologic; Calcium; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Durapatite; Female; Gene Expression; Neoplasm Proteins; Osteoblasts; Osteopontin; Phenotype; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sialoglycoproteins; Strontium; Transcription Factors; Transforming Growth Factor beta | 2003 |
An animal evaluation of a paste of chitosan glutamate and hydroxyapatite as a synthetic bone graft material.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Density; Bone Marrow; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Transplantation; Chitin; Chitosan; Durapatite; Glutamic Acid; Osseointegration; Rats; Skull; Transforming Growth Factor beta | 2003 |
Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
Topics: Animals; Bone Marrow Cells; Bone Morphogenetic Proteins; Cell Differentiation; Ceramics; Durapatite; Growth Differentiation Factor 5; Hematopoietic Stem Cells; Male; Mesoderm; Mice; Osteogenesis; Rats; Rats, Inbred F344; Recombinant Proteins; Transforming Growth Factor beta | 2004 |
Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
Topics: Analysis of Variance; Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Disease Models, Animal; Durapatite; Female; Lumbar Vertebrae; Osseointegration; Probability; Rabbits; Sensitivity and Specificity; Spinal Fusion; Tensile Strength; Transforming Growth Factor beta | 2004 |
Bone growth into a ceramic-filled defect around an implant. The response to transforming growth factor beta1.
Topics: Animals; Bone Development; Bone Nails; Bone Substitutes; Calcium Phosphates; Coated Materials, Biocompatible; Durapatite; Male; Rats; Rats, Sprague-Dawley; Tibia; Titanium; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Cations; Drug Carriers; Drug Implants; Durapatite; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Liposomes; Materials Testing; Osteogenesis; Plasmids; Porosity; Rabbits; Skull Fractures; Transfection; Transforming Growth Factor beta; Treatment Outcome; Wound Healing | 2004 |
Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Diphosphonates; Drug Carriers; Drug Delivery Systems; Durapatite; Fibroblast Growth Factor 2; Heparin; Maleimides; Periodic Acid; Phosphates; Protein Binding; Transforming Growth Factor beta | 2004 |
Development of a novel biomaterial, hydroxyapatite/collagen (HAp/Col) composite for medical use.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Cervical Vertebrae; Collagen; Dogs; Drug Delivery Systems; Durapatite; Fracture Healing; Fractures, Bone; Implants, Experimental; Male; Manufactured Materials; Materials Testing; Osseointegration; Osteogenesis; Radiography; Radius; Spinal Fusion; Transforming Growth Factor beta; Treatment Outcome; Ulna | 2005 |
[Tissue engineered bone regeneration of periosteal cells using recombinant human bone morphogenetic protein 2 induce].
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Cells, Cultured; Collagen; Durapatite; Humans; Lactic Acid; Mice; Mice, Nude; Periosteum; Polymers; Rabbits; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2005 |
Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Topics: Animals; Bone Marrow Transplantation; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Ceramics; Collagen Type I; Drug Carriers; Durapatite; Elasticity; Implants, Experimental; Lumbar Vertebrae; Models, Animal; Osseointegration; Rabbits; Recombinant Proteins; Spinal Fusion; Surgical Sponges; Transforming Growth Factor beta | 2005 |
A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2).
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Cartilage Diseases; Cartilage, Articular; Chondrocytes; Drug Carriers; Durapatite; Lactates; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Polyethylene Glycols; Rabbits; Transforming Growth Factor beta; Wound Healing | 2005 |
Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Collagen; Drug Carriers; Durapatite; Humans; Least-Squares Analysis; Papio anubis; Random Allocation; Recombinant Proteins; Transforming Growth Factor beta | 2005 |
Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularised pedicled bone flap in the human chest.
Topics: Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Carcinoma, Squamous Cell; Durapatite; Graft Survival; Humans; Male; Mandible; Methicillin Resistance; Middle Aged; Mouth Neoplasms; Osteogenesis; Pectoralis Muscles; Plastic Surgery Procedures; Staphylococcal Infections; Surgical Flaps; Surgical Wound Infection; Transforming Growth Factor beta | 2006 |
Bone response to 3D periodic hydroxyapatite scaffolds with and without tailored microporosity to deliver bone morphogenetic protein 2.
Topics: Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Durapatite; Extracellular Matrix; Goats; Porosity; Transforming Growth Factor beta | 2006 |
Electrospun silk-BMP-2 scaffolds for bone tissue engineering.
Topics: Adult; Animals; Birefringence; Bombyx; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcification, Physiologic; Calcium; Cell Culture Techniques; Collagen Type I; DNA; Durapatite; Extracellular Matrix; Fibroins; Gene Expression; Humans; Insect Proteins; Integrin-Binding Sialoprotein; Male; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanostructures; Osteogenesis; Polyethylene Glycols; Sialoglycoproteins; Silk; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Transforming Growth Factor beta; X-Ray Diffraction | 2006 |
A novel hydroxyapatite fiber mesh as a carrier for recombinant human bone morphogenetic protein-2 enhances bone union in rat posterolateral fusion model.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Drug Carriers; Durapatite; Humans; Lumbar Vertebrae; Radiography; Rats; Rats, Wistar; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta | 2006 |
Hydroxyapatite coating of cellulose sponge does not improve its osteogenic potency in rat bone.
Topics: Animals; Bone Substitutes; Cellulose; Coated Materials, Biocompatible; Durapatite; Femoral Fractures; Male; Materials Testing; Osteogenesis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2005 |
In situ osteogenesis of hemimandible with rhBMP-2 in a 9-year-old boy: osteoinduction via stem cell concentration.
Topics: Biocompatible Materials; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Plates; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Child, Preschool; Collagen; Durapatite; Fibroma, Ossifying; Follow-Up Studies; Humans; Male; Mandible; Mandibular Neoplasms; Neoplasm Recurrence, Local; Osteogenesis; Periosteum; Plastic Surgery Procedures; Recombinant Proteins; Stem Cells; Transforming Growth Factor beta | 2006 |
Blood permeability of a novel ceramic scaffold for bone morphogenetic protein-2.
Topics: Albumins; Animals; Blood; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Cattle; Ceramics; Durapatite; Humans; Male; Materials Testing; Microscopy, Electron, Scanning; Permeability; Prostheses and Implants; Rats; Rats, Wistar; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2007 |
The application of a murine bone bioreactor as a model of tumor: bone interaction.
Topics: Animals; Bioreactors; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Durapatite; Female; Mammary Neoplasms, Experimental; Mice; Tissue Engineering; Transforming Growth Factor beta | 2006 |
Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute: an experimental study in dogs.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Coated Materials, Biocompatible; Dogs; Drug Evaluation, Preclinical; Durapatite; Joint Prosthesis; Osseointegration; Osteogenesis; Random Allocation; Transforming Growth Factor beta | 2007 |
Exogenous recombinant human BMP-2 has little initial effects on human osteoblastic cells cultured on collagen type I coated/noncoated hydroxyapatite ceramic granules.
Topics: Alkaline Phosphatase; Apoptosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Substitutes; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Survival; Coated Materials, Biocompatible; Collagen Type I; Dose-Response Relationship, Drug; Durapatite; Humans; Osteoblasts; Osteocalcin; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2007 |
Localized viral vector delivery to enhance in situ regenerative gene therapy.
Topics: Adenoviridae; Adenoviridae Infections; Animals; beta-Galactosidase; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Durapatite; Fractures, Bone; Freeze Drying; Gelatin Sponge, Absorbable; Gene Expression; Genetic Engineering; Genetic Therapy; Genetic Vectors; Implants, Experimental; Injections; Rats; Rats, Inbred F344; Tomography, X-Ray Computed; Transduction, Genetic; Transforming Growth Factor beta | 2007 |
Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Topics: Biocompatible Materials; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Cell Adhesion; Cell Survival; Cells, Cultured; Chitosan; DNA; Durapatite; Humans; Lactic Acid; Nanostructures; Nucleic Acid Conformation; Plasmids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Stem Cells; Surface Properties; Time Factors; Tissue Engineering; Transfection; Transforming Growth Factor beta | 2007 |
Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Adhesion; Cells, Cultured; Drug Carriers; Durapatite; Humans; Lactic Acid; Materials Testing; Mesenchymal Stem Cells; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Transforming Growth Factor beta | 2008 |
Adsorption mechanism of BMP-7 on hydroxyapatite (001) surfaces.
Topics: Adsorption; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Computer Simulation; Durapatite; Static Electricity; Transforming Growth Factor beta | 2007 |
Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Mice; Mice, Nude; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tibial Fractures; Transforming Growth Factor beta; Treatment Outcome | 2008 |
Bone regeneration using a naturally grown HA/TCP carrier loaded with rh BMP-2 is independent of barrier-membrane effects.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcium Phosphates; Durapatite; Humans; Implants, Experimental; Membranes, Artificial; Microscopy, Electron, Scanning; Rabbits; Recombinant Proteins; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2008 |
In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Calcification, Physiologic; Cell Differentiation; Cell Line; Cells, Cultured; Coculture Techniques; Collagen Type I; Durapatite; Embryonic Stem Cells; Female; Gene Expression; Glycolates; Humans; Integrin-Binding Sialoprotein; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteoblasts; Osteocalcin; Osteopontin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sialoglycoproteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2008 |
Effects of culture conditions on osteogenic differentiation in human mesenchymal stem cells.
Topics: Alkaline Phosphatase; Ascorbic Acid; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Coated Materials, Biocompatible; Dose-Response Relationship, Drug; Durapatite; Glycerophosphates; Humans; Mesenchymal Stem Cells; Osteogenesis; Osteopontin; Osteoprotegerin; Time Factors; Transforming Growth Factor beta | 2007 |
Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Drug Carriers; Durapatite; Humans; Polyethylene Glycols; Rabbits; Skull; Transforming Growth Factor beta | 2008 |
Self-inducing shape memory geometric cues embedded within smart hydroxyapatite-based biomimetic matrices.
Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium Phosphates; Carbon; Ceramics; Collagen Type IV; Durapatite; Equipment Design; Implants, Experimental; Male; Materials Testing; Morphogenesis; Neovascularization, Physiologic; Osseointegration; Osteoblasts; Papio ursinus; Porosity; Rectus Abdominis; RNA, Messenger; Skull; Tissue Scaffolds; Transforming Growth Factor beta | 2007 |
Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2.
Topics: Animals; Body Fluids; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcification, Physiologic; Coated Materials, Biocompatible; Drug Carriers; Drug Implants; Durapatite; Fibrin; Gels; Lactic Acid; Male; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Radiography; Rats; Rats, Sprague-Dawley; Skull; Transforming Growth Factor beta | 2008 |
Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Durapatite; Graphite; Humans; Male; Materials Testing; Mice; Microscopy, Electron, Scanning; Nanotubes, Carbon; Osseointegration; Osteogenesis; Prostheses and Implants; Recombinant Proteins; Surface Properties; Transforming Growth Factor beta; X-Ray Diffraction | 2008 |
Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis.
Topics: Animals; Aorta, Abdominal; Calcinosis; Collagen; Disease Models, Animal; Durapatite; Elastin; Femoral Artery; Male; Matrix Metalloproteinase 9; Osteopontin; Rats; Rats, Wistar; Signal Transduction; Transforming Growth Factor beta; Vascular Diseases; Warfarin | 2008 |
Effect of bone sialoprotein and collagen coating on cell attachment to TICER and pure titanium implant surfaces.
Topics: Adult; Cell Adhesion; Cell Count; Cells, Cultured; Coated Materials, Biocompatible; Collagen Type I; Dental Implants; Dental Materials; Durapatite; Humans; Image Processing, Computer-Assisted; Integrin-Binding Sialoprotein; Male; Microscopy, Confocal; Middle Aged; Osteoblasts; Osteocalcin; Osteonectin; Sialoglycoproteins; Surface Properties; Time Factors; Titanium; Transforming Growth Factor beta | 2008 |
A study on a tissue-engineered bone using rhBMP-2 induced periosteal cells with a porous nano-hydroxyapatite/collagen/poly(L-lactic acid) scaffold.
Topics: Animals; Biocompatible Materials; Bone Development; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cells, Cultured; Collagen; Drug Carriers; Durapatite; Lactic Acid; Materials Testing; Mice; Mice, Nude; Nanostructures; Osteogenesis; Periosteum; Polyesters; Polymers; Porosity; Rabbits; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2006 |
Implanting hydroxyapatite-coated porous titanium with bone morphogenetic protein-2 and hyaluronic acid into distal femoral metaphysis of rabbits.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Coated Materials, Biocompatible; Durapatite; Femur; Hyaluronic Acid; Osseointegration; Porosity; Prostheses and Implants; Rabbits; Titanium; Transforming Growth Factor beta | 2008 |
Growth of new bone guided by implants in a murine calvarial model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Dental Implants; Durapatite; Humans; Mice; Models, Animal; Osteogenesis; Recombinant Proteins; Skull; Titanium; Transforming Growth Factor beta | 2008 |
In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically.
Topics: Adipose Tissue; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Cell Differentiation; Cell Transplantation; CHO Cells; Cricetinae; Cricetulus; Durapatite; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Glycolates; Humans; Kinetics; Lactic Acid; Mice; Mice, Nude; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Implantation; Stromal Cells; Tissue Scaffolds; Transforming Growth Factor beta | 2008 |
Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Combined Modality Therapy; Durapatite; Female; Gene Expression Regulation; Genetic Therapy; Humans; Implants, Experimental; Osteogenesis; Osteoporosis; Ovariectomy; Radiography; Rats; Rats, Sprague-Dawley; Stromal Cells; Tissue Engineering; Transfection; Transforming Growth Factor beta | 2008 |
Hydroxyapatite coatings did not increase TGF-beta and BMP-2 secretion in murine J774A.1 macrophages, but induced a pro-inflammatory cytokine response.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Line; Durapatite; Interleukin-6; Lymphotoxin-alpha; Macrophage Activation; Macrophages; Mice; Surface Properties; Titanium; Transforming Growth Factor beta | 2009 |
Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Durapatite; Female; Fibrin; Gelatin; Humans; Kinetics; Male; Microscopy, Electron, Scanning; Rabbits; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2009 |
Experimental study of nano-hydroxyapatite/recombinant human bone morphogenetic protein-2 composite artificial bone.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Durapatite; Humans; Male; Nanoparticles; Rabbits; Radiography; Radionuclide Imaging; Radius; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta; X-Rays | 2010 |
Recombinant human bone morphogenetic protein-2 (rhBMP-2) in the treatment of mandibular sequelae after tumor resection.
Topics: Adult; Ameloblastoma; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Plates; Bone Substitutes; Bone Transplantation; Calcium Phosphates; Collagen; Cutaneous Fistula; Device Removal; Drug Carriers; Durapatite; Equipment Failure; Female; Follow-Up Studies; Humans; Mandibular Neoplasms; Oral Fistula; Plastic Surgery Procedures; Recombinant Proteins; Surgical Mesh; Surgical Wound Dehiscence; Surgical Wound Infection; Transforming Growth Factor beta | 2011 |
A pilot experimental lateral ridge augmentation study using bone morphogenetic protein 2 in dogs.
Topics: Absorbable Implants; Alveolar Ridge Augmentation; Animals; Bone Density; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Bone Regeneration; Bone Substitutes; Bone Transplantation; Collagen; Dental Implantation, Endosseous; Dogs; Durapatite; Humans; Male; Mandible; Osseointegration; Pilot Projects; Recombinant Proteins; Transforming Growth Factor beta | 2010 |
Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2.
Topics: Animals; Bone Diseases; Bone Morphogenetic Protein 2; Bone Regeneration; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Durapatite; Humans; Lactic Acid; Male; Peptides; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Skull; Tissue Scaffolds; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2011 |
Reconstruction of alveolar bone defects using bone morphogenetic protein 2 mediated rabbit dental pulp stem cells seeded on nano-hydroxyapatite/collagen/poly(L-lactide).
Topics: Adipogenesis; Alkaline Phosphatase; Alveolar Process; Animals; Bone Morphogenetic Protein 2; Cell Separation; Cells, Cultured; Collagen; Colony-Forming Units Assay; Dental Pulp; Durapatite; Female; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Nanoparticles; Osteocalcin; Osteogenesis; Plastic Surgery Procedures; Polyesters; Prosthesis Implantation; Rabbits; Recombinant Proteins; Stem Cell Transplantation; Stem Cells; Transforming Growth Factor beta | 2011 |
Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Substitutes; Collagen; Disease Models, Animal; Durapatite; Fracture Healing; Glycerol; Humans; Lumbar Vertebrae; Nanocomposites; Osteitis; Postoperative Complications; Pseudarthrosis; Rats; Rats, Nude; Recombinant Proteins; Spinal Diseases; Spinal Fusion; Transforming Growth Factor beta; X-Ray Microtomography | 2011 |
Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Cattle; Collagen; Delayed-Action Preparations; Durapatite; Humans; Injections; Male; Pilot Projects; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serum Albumin, Bovine; Skull; Transforming Growth Factor beta; Wound Healing; X-Ray Microtomography | 2012 |
The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Topics: Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Bony Callus; Calcium Phosphates; Collagen Type I; Drug Delivery Systems; Durapatite; Eosine Yellowish-(YS); Escherichia coli; Femur; Hematoxylin; Humans; Male; Microscopy, Electron, Scanning; Osteogenesis; Osteogenesis, Distraction; Osteopontin; Osteotomy; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staining and Labeling; Time Factors; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |
Enhancement of osteogenesis by poly(lactide-co-glycolide) sponges loaded with surface-embedded hydroxyapatite particles and rhBMP-2.
Topics: Alkaline Phosphatase; Animals; Bone Marrow Cells; Bone Morphogenetic Protein 2; Collagen; Durapatite; Gene Expression Regulation; Humans; Lactic Acid; Male; Osteocalcin; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Time Factors; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |
Comparative study of fusion rate induced by different dosages of Escherichia coli-derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier.
Topics: Animals; Bone Morphogenetic Protein 2; Drug Carriers; Durapatite; Escherichia coli; Humans; Intervertebral Disc Degeneration; Male; Osteogenesis; Rabbits; Recombinant Proteins; Spinal Fusion; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |
Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum.
Topics: Adipocytes; Adipogenesis; Alkaline Phosphatase; Animals; Anthraquinones; Azo Compounds; Bone Morphogenetic Protein 2; Cell Culture Techniques; Cell Differentiation; Coloring Agents; Core Binding Factor Alpha 1 Subunit; Durapatite; Fetal Blood; Humans; Infant, Newborn; Male; Mesenchymal Stem Cells; Mice; Mice, Nude; Osteoblasts; Osteocalcin; Osteogenesis; Platelet-Rich Plasma; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta; Umbilical Cord | 2012 |
Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery.
Topics: Adipose Tissue; Alkaline Phosphatase; Analysis of Variance; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Calcium Sulfate; Cell Culture Techniques; Cell Differentiation; Durapatite; Enzyme-Linked Immunosorbent Assay; Humans; Mesenchymal Stem Cells; Porosity; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sp7 Transcription Factor; Staining and Labeling; Tissue Engineering; Tissue Scaffolds; Transcription Factors; Transforming Growth Factor beta | 2012 |
BMP-2 tethered hydroxyapatite for bone tissue regeneration: coating chemistry and osteoblast attachment.
Topics: Bone Morphogenetic Protein 2; Bone Regeneration; Cell Adhesion; Cell Line; Coated Materials, Biocompatible; Delayed-Action Preparations; Durapatite; Humans; Osteoblasts; Polyethylene Glycols; Polyethyleneimine; Recombinant Proteins; Transforming Growth Factor beta | 2012 |
In Vivo Study of Hydroxyapatite-coated Hat Type Cervical Intervertebral Fusion Cage Combined With IGF-I and TGF-β1 in the Goat Model.
Topics: Animals; Biocompatible Materials; Bone Matrix; Cervical Vertebrae; Disease Models, Animal; Diskectomy; Drug Therapy, Combination; Durapatite; Goats; Insulin-Like Growth Factor I; Spinal Fusion; Time Factors; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2016 |
Fabrication of crosslinked carboxymethylchitosan microspheres and their incorporation into composite scaffolds for enhanced bone regeneration.
Topics: Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Chitosan; Cross-Linking Reagents; Durapatite; Humans; Iridoids; Microscopy, Electron, Scanning; Microspheres; Muramidase; Ninhydrin; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2013 |
In vitro and in vivo enhancement of osteogenic capacity in a synthetic BMP-2 derived peptide-coated mineralized collagen composite.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Adhesion; Cell Shape; Cells, Cultured; Chromatography, High Pressure Liquid; Coated Materials, Biocompatible; Collagen; Durapatite; Kinetics; Minerals; Osteoblasts; Osteogenesis; Peptides; Rabbits; Recombinant Proteins; RNA, Messenger; Transforming Growth Factor beta | 2016 |
Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Compressive Strength; Diphosphonates; Durapatite; Female; Imidazoles; Implants, Experimental; Lactic Acid; Mice; Mice, Inbred C57BL; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Porosity; Radiography; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Zoledronic Acid | 2013 |
Severe mandibular atrophy treated with a subperiosteal implant and simultaneous graft with rhBMP-2 and mineralized allograft: a case report.
Topics: Aged; Allografts; Alveolar Bone Loss; Alveolar Ridge Augmentation; Atrophy; Bone Morphogenetic Protein 2; Bone Transplantation; Coated Materials, Biocompatible; Cone-Beam Computed Tomography; Dental Implantation, Subperiosteal; Dental Implants; Dental Materials; Dental Prosthesis Design; Durapatite; Female; Follow-Up Studies; Humans; Mandible; Recombinant Proteins; Titanium; Transforming Growth Factor beta | 2014 |
Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Coated Materials, Biocompatible; Dental Implants; Durapatite; Humans; Implants, Experimental; Osseointegration; Recombinant Proteins; Sheep; Surface Properties; Titanium; Transforming Growth Factor beta | 2014 |
Gene expression profile study on osteoinductive effect of natural hydroxyapatite.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Cluster Analysis; Computational Biology; Durapatite; Gene Expression Profiling; Gene Ontology; Gene Regulatory Networks; Mesenchymal Stem Cells; Mice; Osseointegration; Osteogenesis; Powders; Real-Time Polymerase Chain Reaction; Reference Standards; Reproducibility of Results; Signal Transduction; Spectroscopy, Fourier Transform Infrared; Transforming Growth Factor beta | 2014 |
Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere.
Topics: Animals; Biocompatible Materials; Bombyx; Bone and Bones; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Durapatite; Female; Fibroins; Humans; Kinetics; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microspheres; Placenta; Porosity; Pregnancy; Recombinant Proteins; Sodium Chloride; Stress, Mechanical; Time Factors; Transforming Growth Factor beta | 2014 |
Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Transplantation; Drug Carriers; Durapatite; Humans; Lumbar Vertebrae; Male; Recombinant Proteins; Spinal Fusion; Swine; Swine, Miniature; Transforming Growth Factor beta | 2014 |
Bone augmentation using a synthetic hydroxyapatite/silica oxide-based and a xenogenic hydroxyapatite-based bone substitute materials with and without recombinant human bone morphogenetic protein-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Durapatite; Humans; Models, Animal; Rabbits; Random Allocation; Recombinant Proteins; Silicon Dioxide; Skull; Titanium; Transforming Growth Factor beta | 2015 |
The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Morphogenetic Protein 2; Calcium Phosphates; Diabetes Mellitus, Type 1; Disease Models, Animal; Durapatite; Femur; Male; Osteogenesis; Osteoporosis; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Microtomography | 2015 |
BMP2-loaded hollow hydroxyapatite microspheres exhibit enhanced osteoinduction and osteogenicity in large bone defects.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Durapatite; Humans; Microspheres; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 2015 |
Templated repair of long bone defects in rats with bioactive spiral-wrapped electrospun amphiphilic polymer/hydroxyapatite scaffolds.
Topics: Animals; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Differentiation; Cell Survival; Durapatite; Femoral Fractures; Lactates; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osteogenesis; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Tomography, X-Ray Computed; Transforming Growth Factor beta | 2015 |
Exploring the Material-Induced Transcriptional Landscape of Osteoblasts on Bone Graft Materials.
Topics: Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Cell Line, Tumor; Durapatite; Humans; Lactic Acid; Nanostructures; Osteoblasts; Polyesters; Polymers; Principal Component Analysis; Signal Transduction; Tissue Engineering; Tissue Scaffolds; Transcriptome; Transforming Growth Factor beta; Wnt Proteins | 2015 |
Osteogenic potential and synergistic effects of growth factors delivered from a bionic composite system.
Topics: Animals; Bionics; Bone Morphogenetic Protein 2; Durapatite; Femur; Fibroblast Growth Factor 2; Gelatin; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections; Male; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Poloxamer; Porosity; Rats, Sprague-Dawley; Recombinant Proteins; Sus scrofa; Temperature; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2016 |
Osteogenic effect of controlled released rhBMP-2 in 3D printed porous hydroxyapatite scaffold.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Survival; Cells, Cultured; Chitosan; Delayed-Action Preparations; Drug Liberation; Durapatite; Humans; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Microspheres; Molecular Imprinting; Osteogenesis; Porosity; Rabbits; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta | 2016 |
Non-mulberry silk fibroin grafted poly (Є-caprolactone)/nano hydroxyapatite nanofibrous scaffold for dual growth factor delivery to promote bone regeneration.
Topics: Animals; Bombyx; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Line; Delayed-Action Preparations; Drug Delivery Systems; Durapatite; Fibroins; Humans; Nanofibers; Osteoblasts; Osteogenesis; Polyesters; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2016 |
Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release Hydrogel.
Topics: Animals; Biocompatible Materials; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Ceramics; Chitosan; Delayed-Action Preparations; Dogs; Drug Carriers; Durapatite; Humans; Hydrogels; Imaging, Three-Dimensional; Male; Osteogenesis; Porosity; Recombinant Proteins; Spine; Transforming Growth Factor beta; X-Ray Microtomography; Zirconium | 2016 |
[Preparation of hydroxyapatite/chitosan-transforming growth factor-β composite coatings on titanium surfaces and its effect on the attachment and proliferation of osteoblasts].
Topics: Cell Proliferation; Chitosan; Dental Bonding; Durapatite; Microscopy, Electron, Scanning; Osteoblasts; Prospective Studies; Spectroscopy, Fourier Transform Infrared; Surface Properties; Titanium; Transforming Growth Factor beta; Transforming Growth Factors; X-Ray Diffraction | 2016 |
Chitosan/nHAC/PLGA microsphere vehicle for sustained release of rhBMP-2 and its derived synthetic oligopeptide for bone regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Line; Chitosan; Collagen; Delayed-Action Preparations; Durapatite; Humans; Lactic Acid; Male; Mice; Microspheres; Osteoblasts; Osteogenesis; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2017 |
Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Durapatite; Humans; Male; Mice; Rats; Rats, Wistar; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2017 |
Endocultivation: continuous application of rhBMP-2 via mini-osmotic pumps to induce bone formation at extraskeletal sites.
Topics: Animals; Biological Availability; Bone Density; Bone Morphogenetic Protein 2; Drug Delivery Systems; Durapatite; Female; Models, Animal; Osmosis; Osteogenesis; Rats; Rats, Inbred Lew; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2017 |
Augmentation of fracture healing by hydroxyapatite/collagen paste and bone morphogenetic protein-2 evaluated using a rat femur osteotomy model.
Topics: Animals; Biomechanical Phenomena; Bone Morphogenetic Protein 2; Collagen; Durapatite; Femur; Fracture Healing; Male; Models, Animal; Osteotomy; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta; X-Ray Microtomography | 2018 |
Host cell recruitment patterns by bone morphogenetic protein-2 releasing hyaluronic acid hydrogels in a mouse subcutaneous environment.
Topics: Animals; Bone Morphogenetic Protein 2; Delayed-Action Preparations; Durapatite; Endothelial Cells; Humans; Hyaluronic Acid; Hydrogels; Implants, Experimental; Inflammation; Kinetics; Macrophages; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; Nanoparticles; Osteogenesis; Recombinant Proteins; Subcutaneous Tissue; Transforming Growth Factor beta | 2017 |
Repair of the calvarial defect in goat model using magnesium-doped porous hydroxyapatite combined with recombinant human bone morphogenetic protein-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Durapatite; Goats; Humans; Magnesium; Recombinant Proteins; Skull; Tissue Engineering; Transforming Growth Factor beta | 2017 |
Effects of a bone graft substitute consisting of porous gradient HA/ZrO
Topics: Animals; Biomechanical Phenomena; Bone and Bones; Bone Morphogenetic Protein 2; Bone Substitutes; Chitosan; Delayed-Action Preparations; Durapatite; Gelatin; Gene Expression Regulation; Hydrogels; Lumbar Vertebrae; Macaca mulatta; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Osseointegration; Osteogenesis; Porosity; Recombinant Proteins; Transforming Growth Factor beta; Wound Healing; X-Ray Microtomography; Zirconium | 2018 |
Low-intensity pulsed ultrasound (LIPUS) stimulates mineralization of MC3T3-E1 cells through calcium and phosphate uptake.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Calcium; Cell Differentiation; Cell Line; Collagen; Durapatite; In Vitro Techniques; Mice; Osteoblasts; Phosphates; Transforming Growth Factor beta; Ultrasonic Waves | 2018 |
Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Topics: Animals; Biocompatible Materials; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Calcium Sulfate; Cell Line; Cell Survival; Delayed-Action Preparations; Durapatite; Gelatin; Male; Mice; Osteogenesis; Rats, Sprague-Dawley; Recombinant Proteins; Transforming Growth Factor beta; Zoledronic Acid | 2018 |
[Radiological evaluation of dextran sulfate/recombinant human bone morphogenetic protein 2/chitosan composite microspheres combined with coral hydroxyapatite artificial bone in repairing large segmental bone defects].
Topics: Animals; Anthozoa; Bone Morphogenetic Protein 2; Bone Regeneration; Chitosan; Dextran Sulfate; Durapatite; Humans; Hydroxyapatites; Male; Microspheres; Osteogenesis; Rabbits; Recombinant Proteins; Tissue Engineering; Transforming Growth Factor beta | 2017 |
Loading BMP-2 on nanostructured hydroxyapatite microspheres for rapid bone regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Disease Models, Animal; Drug Liberation; Durapatite; Femur; Humans; Imaging, Three-Dimensional; Male; Microspheres; Nanostructures; Rats, Sprague-Dawley; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Transforming Growth Factor beta; X-Ray Diffraction; X-Ray Microtomography | 2018 |
Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Topics: Animals; Biocompatible Materials; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Sulfate; Collagen; Drug Delivery Systems; Durapatite; Gelatin; Male; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Zoledronic Acid | 2019 |
Sequential releasing of VEGF and BMP-2 in hydroxyapatite collagen scaffolds for bone tissue engineering: Design and characterization.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Chitosan; Collagen; Drug Liberation; Durapatite; Humans; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Rats; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2019 |
Use of Recombinant Human Bone Morphogenetic Protein-2 at the C1-C2 Lateral Articulation without Posterior Structural Bone Graft in Posterior Atlantoaxial Fusion in Adult Patients.
Topics: Atlanto-Axial Joint; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Transplantation; Cervical Vertebrae; Clinical Protocols; Congenital Abnormalities; Durapatite; Female; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Reoperation; Retrospective Studies; Transforming Growth Factor beta; Transplantation, Autologous; Transplantation, Homologous | 2019 |
The topography and proliferative activity of cells immunoreactive to various growth factors in rat femoral bone tissues after experimental fracture and implantation of titanium implants with bioactive biodegradable coatings.
Topics: Animals; Bone Morphogenetic Protein 2; Calcium Phosphates; Cell Proliferation; Coated Materials, Biocompatible; Durapatite; Femoral Fractures; Femur; Male; Osteogenesis; Prostheses and Implants; Rats; Surface Properties; Titanium; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2019 |
Hybrid core-shell scaffolds for bone tissue engineering.
Topics: Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Cell Adhesion; Cell Differentiation; Cell Proliferation; Durapatite; Electrochemistry; Humans; Materials Testing; Mesenchymal Stem Cells; Polyesters; Recombinant Proteins; Stress, Mechanical; Tensile Strength; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2019 |
Study of bone repair mediated by recombination BMP-2/ recombination CXC chemokine Ligand-13-loaded hollow hydroxyapatite microspheres/chitosan composite.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Proliferation; Cells, Cultured; Chemokine CXCL13; Chitosan; Delayed-Action Preparations; Durapatite; Humans; Male; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Rabbits; Rats; Recombinant Proteins; Tissue Scaffolds; Transforming Growth Factor beta | 2019 |
The mechanism research of non-Smad dependent TAK1 signaling pathway in the treatment of bone defects by recombination BMP-2-loaded hollow hydroxyapatite microspheres/chitosan composite.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Chitosan; Durapatite; Male; Materials Testing; Microspheres; Osteogenesis; Rabbits; Recombinant Proteins; Transforming Growth Factor beta | 2019 |
Bone inductivity comparison of control versus non-control released rhBMP2 coatings in 3D printed hydroxyapatite scaffold.
Topics: Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Durapatite; Humans; In Vitro Techniques; Kinetics; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Printing, Three-Dimensional; Rabbits; Recombinant Proteins; Signal Transduction; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta | 2020 |
Sinus Floor Augmentation Using Recombinant Human Bone Morphogenetic Protein-2 With Hydroxyapatite: Volume Assessment.
Topics: Adult; Bone Morphogenetic Protein 2; Durapatite; Female; Humans; Male; Maxillary Sinus; Middle Aged; Recombinant Proteins; Sinus Floor Augmentation; Transforming Growth Factor beta | 2020 |
A multifunctional fusion peptide for tethering to hydroxyapatite and selective capture of bone morphogenetic protein from extracellular milieu.
Topics: Binding Sites; Bone Morphogenetic Protein 2; Chromatography, Affinity; Delayed-Action Preparations; Durapatite; Fibrinogen; Humans; Peptides; Recombinant Fusion Proteins; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Biomimetic UHMWPE/HA scaffolds with rhBMP-2 and erythropoietin for reconstructive surgery.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Diseases; Bone Morphogenetic Protein 2; Bone Regeneration; Drug Carriers; Durapatite; Erythropoietin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nanocomposites; Neovascularization, Physiologic; Plastic Surgery Procedures; Polyethylenes; Porosity; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Effect of bone morphogenetic protein-2/hydroxyapatite on ankle fusion with bone defect in a rabbit model: a pilot study.
Topics: Animals; Ankle Joint; Arthrodesis; Autografts; Bone Morphogenetic Protein 2; Bone Screws; Bone Substitutes; Bone Transplantation; Disease Models, Animal; Drug Carriers; Durapatite; Male; Osteogenesis; Pilot Projects; Rabbits; Recombinant Proteins; Tibia; Tomography, X-Ray Computed; Transforming Growth Factor beta; Treatment Outcome | 2020 |
Bio-inspired polymeric iron-doped hydroxyapatite microspheres as a tunable carrier of rhBMP-2.
Topics: Bone Morphogenetic Protein 2; Bone Regeneration; Durapatite; Humans; Iron; Microspheres; Osteogenesis; Recombinant Proteins; Transforming Growth Factor beta | 2021 |
A novel nano-hydroxyapatite/synthetic polymer/bone morphogenetic protein-2 composite for efficient bone regeneration.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Durapatite; Male; Mice; Osteogenesis; Polymers; Rats; Rats, Sprague-Dawley; Spinal Fusion; Transforming Growth Factor beta | 2021 |
Effect of melatonin/BMP-2 co-delivery scaffolds on the osteoclast activity.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Resorption; Cathepsin K; Cell Differentiation; Cell Survival; Chitosan; Drug Delivery Systems; Durapatite; In Vitro Techniques; Melatonin; Mice; Microscopy, Electron, Scanning; Osteoclasts; RAW 264.7 Cells; Recombinant Proteins; Stress, Mechanical; Thermogravimetry; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2021 |
Effects of rhBMP-2 on Bone Formation Capacity of Rat Dental Stem/Progenitor Cells from Dental Follicle and Alveolar Bone Marrow.
Topics: Animals; Bone Morphogenetic Protein 2; Cell Differentiation; Cells, Cultured; Collagen; Dental Sac; Durapatite; Gene Expression; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Osteocalcin; Osteogenesis; Osteopontin; Polyesters; Rats, Sprague-Dawley; Recombinant Proteins; Stem Cells; Transforming Growth Factor beta | 2021 |
Effectiveness of xenogeneic and synthetic bone-block substitute materials with/without recombinant human bone morphogenetic protein-2: A preclinical study using a rabbit calvarium model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Cattle; Durapatite; Humans; Rabbits; Recombinant Proteins; Skull; Transforming Growth Factor beta; X-Ray Microtomography | 2021 |
A Naringin-loaded gelatin-microsphere/nano-hydroxyapatite/silk fibroin composite scaffold promoted healing of critical-size vertebral defects in ovariectomised rat.
Topics: Animals; Biocompatible Materials; Bone Morphogenetic Protein 2; Bone Regeneration; Cell Differentiation; Durapatite; Female; Fibroins; Flavanones; Gelatin; Male; Mesenchymal Stem Cells; Microspheres; Osteogenesis; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds; Transforming Growth Factor beta; X-Ray Microtomography | 2021 |
Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) with Hydroxyapatite Carrier in Induced Membrane Technique: A Retrospective Propensity Score-Matched Study.
Topics: Bone Morphogenetic Protein 2; Durapatite; Humans; Propensity Score; Recombinant Proteins; Retrospective Studies; Transforming Growth Factor beta | 2022 |
Bone Regeneration of a 3D-Printed Alloplastic and Particulate Xenogenic Graft with rhBMP-2.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Dogs; Durapatite; Humans; Jaw; Jaw Abnormalities; Maxillofacial Development; Printing, Three-Dimensional; Recombinant Proteins; Skull; Transforming Growth Factor beta | 2021 |